Home

Christy J. Oliger

CIK 1822092 · last filed 2026-07-29

Christy J. Oliger is a corporate insider who has filed 30 SEC Form 4 insider transactions across 9 companies since 2020. The most recent filing, for BCAX, was dated Jul 29, 2026. Current disclosed insider exposure totals $30.2K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$30.2K

Companies

9

Total Filings

30

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BCAX Director — $27.51 — $0 1 2026-07-29
NUVL Director 0 $123.96 $0 $0 3 2026-07-15
VERA Director — $32.02 — $0 3 2026-05-26
KPTI Director 15,508 $1.95 $30.2K $0 7 2026-05-26
REPL Director — $12.86 — $0 6 2026-04-07
LAVA Therapeutics NV (LVTX) Delisted Director — $1.74 — $0 2 2025-11-17
RayzeBio, Inc. (RYZB) Delisted Director — $62.49 — $0 1 2024-02-27
REATA PHARMACEUTICALS INC (RETA) Delisted Director 0 $172.36 $0 $0 5 2023-09-26
Sierra Oncology, Inc. (SRRA) Delisted Director — $54.99 — $0 2 2022-07-01

Recent Filings

30 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-29 BCAX Grant (A) — $0 EDGAR
2026-07-15 NUVL Mixed −7,415 -$164.2K EDGAR
2026-06-18 NUVL Grant (A) +3,444 $0 EDGAR
2026-05-26 VERA Grant (A) — $0 EDGAR
2026-05-26 KPTI Grant (A) +15,508 $0 EDGAR
2026-04-07 REPL Grant (A) — $0 EDGAR
2025-11-17 LAVA Therapeutics NV (LVTX) Delisted Disp (D) — $0 EDGAR
2025-06-20 NUVL Grant (A) +3,971 $0 EDGAR
2025-05-29 KPTI Grant (A) — $0 EDGAR
2025-05-16 VERA Grant (A) — $0 EDGAR
Showing 1–10 of 30
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.